That's not strictly correct. An MoU can indeed be a legally binding agreement (in Australia anyway) if its terms are expressed as creating the same.
With regard to the Sinopharm MoU, the issue is not worth being too concerned about. If JAT has products for sale which are appealing to the Chinese market and Sinopharm has thousands of sales channels for those types of products, the process to minting money is pretty uncomplicated IMO - if the products are priced correctly.
Ann: JAT signs MOU with Sinopharm, page-27
-
- There are more pages in this discussion • 35 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add JAT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
43.0¢ |
Change
-0.020(4.44%) |
Mkt cap ! $58.28M | |||
| Open | High | Low | Value | Volume |
| 43.5¢ | 43.5¢ | 42.5¢ | $31.64K | 73.78K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 47262 | 42.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 43.0¢ | 29500 | 1 |
View Market Depth
| Last trade - 14.31pm 22/11/2024 (20 minute delay) ? |
| JAT (ASX) Chart |
